These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 2023219)

  • 41. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of transforming growth factor-beta and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: effect of Tisseel.
    Saed GM; Kruger M; Diamond MP
    Wound Repair Regen; 2004; 12(5):557-64. PubMed ID: 15453838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.
    Kubo M; Ihn H; Yamane K; Tamaki K
    J Rheumatol; 2002 Dec; 29(12):2558-64. PubMed ID: 12465152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
    Wu MH; Yokozeki H; Takagawa S; Yamamoto T; Satoh T; Kaneda Y; Katayama I; Nishioka K
    Gene Ther; 2004 Jan; 11(2):170-80. PubMed ID: 14712301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heparan sulfate-dependent ERK activation contributes to the overexpression of fibrotic proteins and enhanced contraction by scleroderma fibroblasts.
    Chen Y; Leask A; Abraham DJ; Pala D; Shiwen X; Khan K; Liu S; Carter DE; Wilcox-Adelman S; Goetinck P; Denton CP; Black CM; Pitsillides AA; Sarraf CE; Eastwood M
    Arthritis Rheum; 2008 Feb; 58(2):577-85. PubMed ID: 18240216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Connective tissue metabolism including cytokines in scleroderma.
    Smith EA
    Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulated expression of decorin and the decorin gene in fibroblasts cultured from patients with localized scleroderma.
    Izumi T; Tajima S; Nishikawa T
    Arch Dermatol Res; 1995; 287(5):417-20. PubMed ID: 7625849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by transforming growth factor-beta1, interleukin-4, and matrix collagen.
    Kuroda K; Okamoto O; Shinkai H
    J Invest Dermatol; 1999 May; 112(5):706-10. PubMed ID: 10233760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Transforming growth factor-beta and its receptors in scleroderma].
    QIAN H; ZHENG M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
    Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
    Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts.
    Yamamoto T; Eckes B; Krieg T
    Arch Dermatol Res; 2000 Nov; 292(11):556-61. PubMed ID: 11194894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.
    Sato M; Shegogue D; Gore EA; Smith EA; McDermott PJ; Trojanowska M
    J Invest Dermatol; 2002 Apr; 118(4):704-11. PubMed ID: 11918720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The transcription factor JunD mediates transforming growth factor {beta}-induced fibroblast activation and fibrosis in systemic sclerosis.
    Palumbo K; Zerr P; Tomcik M; Vollath S; Dees C; Akhmetshina A; Avouac J; Yaniv M; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2011 Jul; 70(7):1320-6. PubMed ID: 21515915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in scleroderma.
    Feghali CA; Boulware DW; Levy LS
    J Rheumatol; 1992 Aug; 19(8):1212-9. PubMed ID: 1404156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta.
    Rudnicka L; Varga J; Christiano AM; Iozzo RV; Jimenez SA; Uitto J
    J Clin Invest; 1994 Apr; 93(4):1709-15. PubMed ID: 7512991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis.
    Kuroda K; Shinkai H
    Arch Dermatol Res; 1997 Sep; 289(10):567-72. PubMed ID: 9373715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
    Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture.
    Uitto J; Bauer EA; Eisen AZ
    J Clin Invest; 1979 Oct; 64(4):921-30. PubMed ID: 90059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
    McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
    Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
    Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
    Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.